Unlisted
A Randomized Phase 2 Study of Casdozokitug in Combination With Toripalimab Plus Bevacizumab in Participants With Unresectable and/or Locally Advanced or Metastatic Hepatocellular Carcinoma(CHS-388-202)
- Details
ClinicalTrials.gov ID:
NCT06679985
Diagnosis Type:
NA
USOR Number:
- Address
,
P: